Sum-Yin Chan
Overview
Explore the profile of Sum-Yin Chan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsoi H, Lok J, Man E, Cheng C, Leung M, You C, et al.
J Pathol
. 2023 Aug;
261(2):156-168.
PMID: 37555303
Aromatase inhibitors (Ais) are used as adjuvant endocrine therapy for oestrogen receptor-positive (ER+ve) post-menopausal breast cancer patients. Ais, by inhibiting the enzyme aromatase, block the conversion of androgen to oestrogen,...
2.
Tsoi H, Fung N, Man E, Leung M, You C, Chan W, et al.
Cancers (Basel)
. 2023 May;
15(8).
PMID: 37190199
About 70% of breast cancer patients are oestrogen receptor-positive (ER +ve). Adjuvant endocrine therapy using tamoxifen (TAM) is an effective approach for preventing local recurrence and metastasis. However, around half...
3.
Lee V, Chan S, Tam Y, Chau T, Chan J, Chan S, et al.
Int J Infect Dis
. 2023 Apr;
132:40-49.
PMID: 37072051
Objectives: We sought to identify the predictors of delayed viral clearance in patients with cancer with asymptomatic COVID-19 when the SARS-CoV-2 Omicron variants prevailed in Hong Kong. Methods: All patients...
4.
Tsoi H, Tsang W, Man E, Leung M, You C, Chan S, et al.
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293165
Breast cancer is a heterogeneous disease. Tamoxifen is frequently used to treat ER-positive breast cancer. Our team has identified a novel splice variant of NCOR2, BQ323636.1 (BQ), that mediates tamoxifen...
5.
Lee V, Tsang R, Lo A, Chan S, Chung J, Tong C, et al.
Cancers (Basel)
. 2022 Jul;
14(13).
PMID: 35805058
(1) Background: SMARCB1 (INI-1)-deficient sinonasal carcinoma is a rare sinonasal malignancy; since its discovery and description in 2014, less than 200 cases have been identified. It is almost impossible to...
6.
Chan S, OSullivan B, Huang S, Chau T, Lam K, Chan S, et al.
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454830
(1) Background: NPC patients with de novo distant metastasis appears to be a heterogeneous group who demonstrate a wide range of survival, as suggested by growing evidence. Nevertheless, the current...
7.
Mok K, Tsoi H, Man E, Leung M, Chau K, Wong L, et al.
Clin Transl Med
. 2021 Nov;
11(11):e578.
PMID: 34841695
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are members of the voltage-gated cation channel family known to be expressed in the heart and central nervous system. Ivabradine, a small molecule HCN channel-blocker,...
8.
Lau K, Cheung B, Lam K, Chan S, Lam K, Yeung C, et al.
BMC Infect Dis
. 2021 Nov;
21(1):1148.
PMID: 34758746
Background: Tuberculosis (TB) reactivation has been increasingly identified following immune checkpoint inhibitor (ICI) therapy for cancer patients. However there has been no report on TB reactivation in the gastrointestinal tract....
9.
Tsoi H, Man E, Leung M, Mok K, Chau K, Wong L, et al.
Clin Transl Med
. 2021 Oct;
11(10):e554.
PMID: 34709749
No abstract available.
10.
Chan S, Chau S, Chan S, Tong C, Lam K, Kwong D, et al.
Cancer Control
. 2021 Sep;
28:10732748211047117.
PMID: 34565216
Background: Nasopharyngeal carcinoma (NPC) is endemic in Hong Kong with a skewed geographical and ethnic distribution. We performed an epidemiological study of NPC in Cheung Chau Island, a fishing village...